Protagenic Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
4.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
0.00
|
0.00
|
0.00
|
0.00%
|
|
2022-09-30
|
0.00
|
-0.05
|
-0.05
|
0.00%
|
|
2022-06-30
|
0.00
|
-0.04
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.09
|
-0.05
|
0.04
|
44.44%
|
|
2021-12-31
|
-0.09
|
-0.05
|
0.04
|
44.44%
|
|
2021-09-30
|
-0.08
|
-0.05
|
0.03
|
37.50%
|
|
2021-06-30
|
0.00
|
-0.11
|
0.00
|
0.00%
|
|
2021-03-31
|
0.00
|
-0.11
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.14
|
|
2021-12-31
|
-0.32
|
|
2020-12-31
|
-0.30
|
|
2019-12-31
|
-0.16
|
|
2018-12-31
|
-0.25
|
|
2017-12-31
|
-0.21
|
|
2016-12-31
|
-0.26
|
|
2015-12-31
|
-85755.90
|
|
2008-12-31
|
-2327044.54
|
|
2001-12-31
|
86446.54
|
|
2000-12-31
|
1694534.60
|
|
1999-12-31
|
328926.50
|
|
1998-12-31
|
1371136.00
|